Antifungal Agents and Antifungal Susceptibility Testing

Revankar, Sanjay G.; Graybill, John R.; Patterson, Thomas F.

doi:10.1002/9780470688618.taw0134

Cited by 2 publications

(1 citation statement)

References 198 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Terbinafine is a well-known allylamine agent used for the treatment of superficial fungal infections (10), yet some infections cannot be successfully treated with terbinafine. Recently, Mukherjee et al (11) reported an increased trend of minimum inhibitory concentrations (MICs) of T. rubrum strains against terbinafine.…”

Section: Introductionmentioning

confidence: 99%

In-Vitro Evaluation of Antifungal Activity of Terbinafine and Terbinafine Nano-Drug Against Clinical Isolates of Dermatophytes

Motedayen

Hashemi

Rezaei

et al. 2018

Jundishapur J Microbiol

View full text Add to dashboard Cite

Background: Due to long-term treatment of dermatophytic lesions, such as tinea unguium and using antifungal drugs, which cause side effects, it is essential to investigate new antifungal drugs with greater absorption and fewer side effects, such as nanodrugs. Trichophyton rubrum and Microsporum canis are important dermatophyte species. To investigate new strategy treatment, researchers have tried to find a new drug with extensive therapeutic effects and short-duration treatment. In this context, nano-drugs have gained great interest in improving the efficacy of antifungal properties compared to commercial drugs.

show abstract

Section: Introductionmentioning

confidence: 99%

In-Vitro Evaluation of Antifungal Activity of Terbinafine and Terbinafine Nano-Drug Against Clinical Isolates of Dermatophytes

Motedayen

Hashemi

Rezaei

et al. 2018

Jundishapur J Microbiol

View full text Add to dashboard Cite

show abstract

Antifungal susceptibility of clinically significant candida species by disk diffusion method

Edula¹

2021

IJMMTD

View full text Add to dashboard Cite

Antifungal susceptibility of candida. To perform antifungal susceptibility testing on candida isolates by disk diffusion method & study its susceptibility pattern. The present study was conducted in the department of Microbiology in a tertiary care hospital in Hyderabad from January 2013 to June 2014, with prior approval of the Institutional Ethics Committee. The present study was designed to perform antifungal susceptibility test on Candida isolates by Disk Diffusion Method and study its susceptibility pattern. 102 Candida isolates were subjected to Antifungal susceptibility testing by Disk diffusion method using Mueller-Hinton Agar + 2% Glucose and 0.5 μg/mL Methylene Blue Dye (GMB) Mediumas per CLSI guidelines. : Antifungal susceptibility test shows that C. albicans is more susceptible to all the antifungal agents tested. Resistance to azole group of drugs was more pronounced in non-albicans candida spp. Voriconazole seemed to be superior to Fluconazole with a better susceptibility in the Fluconazole resistant strains also.Findings of the antifungal susceptibility test suggest that Candida spp., differ in their susceptibility to antifungal agents. Antifungal susceptibility testing of Candida isolates will be helpful in guiding physicians to select the appropriate antifungal drug so that therapeutic failures can be avoided thus decreasing patient morbidity and mortality.

show abstract

Antifungal Agents and Antifungal Susceptibility Testing

Cited by 2 publications

References 198 publications

In-Vitro Evaluation of Antifungal Activity of Terbinafine and Terbinafine Nano-Drug Against Clinical Isolates of Dermatophytes

In-Vitro Evaluation of Antifungal Activity of Terbinafine and Terbinafine Nano-Drug Against Clinical Isolates of Dermatophytes

Antifungal susceptibility of clinically significant candida species by disk diffusion method

Contact Info

Product

Resources

About